Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04776655
Title Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB (LIBImAb)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Azienda Unita Sanitaria Locale Reggio Emilia

colorectal adenocarcinoma

colorectal cancer


Bevacizumab + Fluorouracil + Irinotecan + Leucovorin

Cetuximab + Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST